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Abstract
We present an extension to literature-based discovery that goes beyond making discoveries to a principled way of
navigating through selected aspects of some biomedical domain. The method is a type of “discovery browsing” that
guides the user through the research literature on a specified phenomenon. Poorly understood relationships may be
explored through novel points of view, and potentially interesting relationships need not be known ahead of time. In
a process of “cooperative reciprocity” the user iteratively focuses system output, thus controlling the large number
of relationships often generated in literature-based discovery systems. The underlying technology exploits SemRep
semantic predications represented as a graph of interconnected nodes (predication arguments) and edges (predicates).
The system suggests paths in this graph, which represent chains of relationships. The methodology is illustrated with
depressive disorder and focuses on the interaction of inflammation, circadian phenomena, and the neurotransmitter
norepinephrine. Insight provided may contribute to enhanced understanding of the pathophysiology, treatment, and
prevention of this disorder.
Introduction
Sophisticated methods are needed to supplement traditional information retrieval tools for effectively exploiting the
large amount of online textual resources currently available. An active area of research in biomedicine in this regard
is literature-based discovery (LBD), the primary goal of which is to help researchers make new discoveries by gen-
erating novel hypotheses. As pioneered by Swanson,1 the basic underlying principle of the LBD paradigm is that
relations A − B and B − C may be known, yet relation A − C has gone unnoticed. Earlier LBD systems2, 3, 4 used
concept cooccurrence as their primary mechanism for representing relations. Since only some cooccurrences underlie
“interesting” relations, this has drawbacks, which have been addressed first by Hristovski et al.5 and later by Cohen et
al.6 with the use of semantic relations. The use of discovery patterns5 is a further refinement for focusing on useful
relations. One such pattern5 is Maybe treats, which says (in part) that a therapeutic agent C maybe treats disease A
if the level of an important measurement B is typically increased in patients with disease A and if C is able to reduce
the level of B. Additional discovery patterns have been investigated.7, 8
We present a novel LBD methodology incorporating semantic predications and graph-based methods in order to guide
researchers through the relevant literature on a user-specified biomedical phenomenon. The motivation is to extend
LDB methodology beyond making discoveries to a principled way of navigating through selected aspects of some
research area.9 An additional goal is to go beyond document retrieval in response to a query by revealing crucial
relationships in the domain, which may evolve as the user exploits the method. Related work in network analysis of
microarray data is becoming widely used in systems-based research for drug discovery.10
LBD provides the ability to uncover previously implicit or unnoticed relationships in the research literature, but has
been primarily used when component relationships of the final discovery are already known. In the method we propose,
it is not necessary to know ahead of time which relationships may be useful for guiding the research process. Only
the general content area need be specified. The method might be thought of as “discovery browsing,” using graph
theoretic paths to generalize Hristovski’s discovery patterns, not with the purpose of necessarily making a discovery,
but of explicating poorly understood relationships, by providing novel points of view on some research problem. The
method involves an interaction between user decisions and system results. Such “cooperative reciprocity” focuses
system output iteratively based on stipulations that bring relevant relations into clearer focus by narrowing choices,
thus controlling the explosion of potential relationships often generated in LBD.
1514
The underlying technology depends on semantic predications extracted from MEDLINE citations using SemRep11
and represented as a large graph of interconnected nodes (predication arguments) and edges (predicates). The graph-
theoretic constructs degree centrality and path analysis are used to suggest paths in this graph, which represent chains




The predications for this study were provided by the SemRep system,11 which relies on biomedical domain knowledge
in the Unified Medical Language System (UMLS). Access to the UMLS Metathesaurus is provided by MetaMap,12
while a set of semantic relationships (predications) is extracted based on the UMLS Semantic Network. For example,
SemRep extracts the relationship: “Leptin STIMULATES Serotonin” from text “CNS serotonin activated by leptin
modulates sympathetic outflow to the skeleton.” Although coverage of text processed by SemRep is a limiting factor
in this work, the expressiveness of semantic predications positively contributes to the discovery process. Several
evaluations of SemRep (e.g. Ahlers et al.13) indicate that precision is near 75%. SemRep has been used to extract
nearly 25 million semantic predication instances from some 7 million MEDLINE citations (titles and abstracts dating
from 1999 through 2010). These are stored in a MySQL database, which was exploited for this work.
Literature-based discovery
Swanson’s1 paradigm is based on concepts A and C coming from two different, nonoverlapping, domains. The goal
is to find an intermediate concept B, which occurs with both A and C, and validates a new, earlier unknown, A − C
relationship. Such a discovery is called an open discovery. Another type of discovery, a closed discovery, assumes
that a relationship A − C is known. Then, a common concept B and relations A − B and B − C are to be found in
order to explicate the relationship A− C.
The aim of our work is to expand the B element of the A−B − C paradigm. Our methodology considers B not as a
single concept, but as a subchain of intermediate concepts, where A−B − C has the form in (1), where n ∈ [1,∞).
A− (B1 −B2 −B3 − ...−Bn)− C (1)
Investigation of possible chains of relationships may result in a discovery (either open or closed). Swanson1 intro-
duced the possibility of having a chain of Bs between A and C, but this has not been extensively exploited. We use
semantic predications to represent these relationships, and we decided to use graphs as a medium for representing the
predications. Referring to graph theory terminology, we implement discovery chains as paths in a graph.
Graph theory
A graph is a representation of connections (edges) between objects (nodes). Graphs, also known as networks, are
extensively studied in social network analysis and the Semantic Web. Graph theory is a set of functions and measures
pertaining to graph properties. One such measure used in this paper is degree centrality, which measures the connect-
edness of nodes in a graph. A node with more connections (relationships) to other nodes has higher degree centrality.
Freeman14 describes degree centrality as an indicator of the communication activity in a social network. The impor-
tance of high connectivity is also seen in gene interaction networks (p53, for example).15 In our case degree centrality
may be considered as an indicator of the principal substances in the domain for which the graph was constructed. The




In graph theory, a path is a sequence of edges connecting any two nodes in the graph. Paths may be of any length. The
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shortest is of length 1:
A−B (3)
The longest is of length N − 1, where N is the number of nodes in the graph:
X1 −X2 − ...−XN (4)
In Semantic Web research on ranking paths of semantic associations Anyanwu et al.16 exploit the notion of “pre-
dictability.” In their results longer paths more likely reveal rare and uncommon associations.
Dupont et al.17 discuss many walking approaches in a graph (edge passages), which may be also understood as
extraction of paths from the graph. The definitions of maximal length of the edge passage (k-walk) and nodes of
interest are based on this work. The nodes of interest are the start and end points of a walk in a graph. For them, length
of the walk is the number of intermediate nodes visited during a walk between nodes of interest. We measure path
length by the number of edges between the start and end nodes.
Methods
Overview
The procedure for exploiting paths in a graph to facilitate discovery browsing involves several steps: creating a graph
of relevant predications, extracting and ranking paths, and finally, inspecting a small subgraph based on selected
paths. At several steps in the process, system output is filtered based on user stipulation, representing the cooperative
reciprocity involved in uncovering research insights in the domain. A crucial assumption of the system is that the user
brings to bear domain knowledge as part of the process of navigating and focusing in the selected area of interest.
Creating the initial graph is an iterative process in which the user specifies a seed concept to extract predications from
the SemRep predication database. (For this project, extracted predications were limited to those with one of the sub-
stance interaction predicates: STIMULATES, INHIBITS, INTERACTS WITH, and COEXISTS WITH.) Concepts in the
graph are ranked by degree centrality, and a new seed concept is selected from those highest on the list, which is used
to extract additional predications to be added to the growing graph. When a graph of sufficient size to produce “inter-
esting” results has been generated, paths between stipulated concepts are extracted and ranked, also based on degree
centrality. Finally, the user selects paths for further analysis. We will illustrate system processing with depressive
disorder as the domain of interest.
Create graph
Serotonin was selected as the seed concept for investigating depression, since it is known to be a prominent neu-
rotransmitter in this disorder. We extracted all predications from the database that had an argument containing the
string “seroton” (ignoring case). In addition to “Serotonin” this included 183 concepts, such as “serotonin receptor,”
“Serotonin Agonists,” “Serotonin Agents,” and “Serotonin 5-HT-3 Receptor.” (This was an implementation expedient.
In the future, ontology resources will be exploited.) Retrieved predications were loaded into a graph consisting of
1561 nodes (concepts) and 7061 edges (predications) using the NetworkX18 software package written in the Python
programming language. A path of length one in this graph represents all the predication instances in the database hav-
ing the two nodes as either subject or object. For example, the path “Estradiol-stimulates-Serotonin” represents two
instances of the corresponding predication extracted from MEDLINE citations (PMIDs: 16736471 and 19168037).
Links between an edge in the graph and sentences in citations from which corresponding predications were extracted
are maintained by the system.
As a first step in expanding this graph, we calculated degree centrality and ranked the results. Ignoring the concepts
containing “serotonin,” melatonin was high on this list, and was chosen to expand the serotonin graph. This was a
user choice which focused the subsequent graph on a particular aspect of depression. Other substances high on the
degree centrality list, which could have been selected, were “Estrogens,” “Dopamine,” and “Corticosterone.” We then
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retrieved all predications from the SemRep predication database that had an argument containing the string “melato”
(ignoring case). In addition to “Melatonin,” this included 126 concepts, such as “Melatonin Receptors” and “Receptor,
Melatonin, MT2.” The resultant graph (containing both serotonin- and melatonin-related concepts) consisted of 2207
nodes (concepts) and 11,752 edges (predications).
The growing graph of predications for depression was expanded a third (and final) time. Degree centrality was again
calculated and the results ranked. Before prominent concepts were selected from this list, a stop list (based on user
domain knowledge) was applied to remove uninformative concepts (e.g. “Pharmaceutical Preparations”), classes of
both drugs and body substances (e.g. “Antidepressive Agents,” “agonists”), and physiologically general terms (e.g.
“Water,” “Oils”). Serotonin- and melatonin-related concepts were also ignored since predications with them were
already in the graph. The top 140 concepts from this filtered degree centrality list were used in another query to the
predication database and the retrieved predications were added to the graph. The resulting graph of predications for
the depression study, consisting of 22,828 nodes (concepts) and 435,437 edges (predications), formed the basis for
further processing.
Extract paths
The next step was to extract paths from the graph, which, as in constructing the graph, involved an interaction of system
output and user stipulations. Serotonin and melatonin were selected as anchors, and all paths of length four between
them were extracted from the graph using the depth-first algorithm.19 This value was selected as a compromise. Longer
paths are likely to provide more revealing results for discovery;16 however, considerations of processing time with the
current implementation imposed this limitation. The total number of paths extracted was 4,206,647, and all had the
form:
[Melatonin(A)]−B1 −B2 −B3 − [Serotonin(C)] (5)
Before proceeding, we removed all paths in which one of the five concepts was on the stop list of general and un-
informative concepts noted above. (Such concepts “crept” into the graph by being arguments of predications with
non-stopped concepts.) 3,840,958 remained, and a composite degree centrality score was computed for each. This





The list of paths was ranked based on the composite degree centrality score.
As a further step in limiting the number of paths for analysis, we selected only those containing the concept “CLOCK,”
based on domain knowledge that recent research implicates the clock genes in depression.20 The remaining paths
(16,141) had one of the following patterns:
[Melatonin(A)]− [CLOCK(B1)]−B2 −B3 − [Serotonin(C)] (7)
[Melatonin(A)]−B1 − [CLOCK(B2)]−B3 − [Serotonin(C)] (8)
[Melatonin(A)]−B1 −B2 − [CLOCK(B3)]− [Serotonin(C)] (9)
We further focused this list by eliminating concepts that we chose not to consider at this point. Paths with concepts
such as “Glucose,” “Antibodies,” “Lipopolysaccharides,” “Kinases” etc. were removed (again, based on user domain
knowledge), leaving 5,406 paths.
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Analyze paths













13. [Melatonin]-[Interleukin-1 beta]-[Interferon Type II]-[CLOCK]-[Serotonin]
14. [Melatonin]-[Interleukin-6]-[Norepinephrine]-[CLOCK]-[Serotonin]
15. [Melatonin]-[CLOCK]-[Norepinephrine]-[Interleukin-6]-[Serotonin]
16. [Melatonin]-[Insulin]-[Interferon Type II]-[CLOCK]-[Serotonin]
17. [Melatonin]-[CLOCK]-[Dopamine]-[Interleukin-1 beta]-[Serotonin]
18. [Melatonin]-[Interleukin-1 beta]-[Dopamine]-[CLOCK]-[Serotonin]
19. [Melatonin]-[Interleukin-6]-[Interferon Type II]-[CLOCK]-[Serotonin]
20. [Melatonin]-[Insulin]-[Dopamine]-[CLOCK]-[Serotonin]
Eleven unique concepts are involved in these paths: “Interleukin-1 beta,” “Interleukin-6,” “Glutamate,” “Dopamine,”
“Norepinephrine,” “Insulin,” “Cholesterol,” and “Interferon type II” (in addition to the stipulated “Serotonin,” “Mela-
tonin,” and “CLOCK”). The graphical representation of these paths is shown in Figure 1. Numbers on the edges in
Figure 1 show the number of predication instances (limited to substance interaction predicates) represented by that
edge. Links to the corresponding citation sentences are maintained by the system and underpin the guidance provided
to the user. It should be noted that there is considerable overlap among the predications represented in the paths. Edges
with fewer than ten predications are dashed in this graph. We then filtered the subgraph further to include only those
connections that occurred ten times or more, thus eliminating “Dopamine.” This filtering also highlights the more
direct connection between CLOCK and melatonin, which was not the initial intent of this exploration, but nevertheless
is an indication that this visualization highlights important known relationships.
Figure 1: Graph representing the top twenty paths. Numbers on the edges show the number of predication instances.
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There are several “stories” implicit in Figure 1. We further decided to concentrate on just one, namely the interactions
among melatonin, the clock genes, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and norepinephrine, as shown
in Figure 2.
Figure 2: User selected subgraph.
Results
Each of the 95 predications found in Figure 2 was analyzed for SemRep accuracy, and it was determined that 88%
were correct. Each of the citations from which these predications had been extracted was then inspected. In general
we found that even incorrect predications often reveal relevant, perhaps unknown, relationships that can in turn lead
to further research. Below we give examples of predications drawn from citations that provide insight into the three
aspects of depression covered by Figure 2: melatonin and CLOCK, melatonin and the two proinflammatory cytokines,
the two cytokines and norepinephrine.
CLOCK stimulates Melatonin: Although this predication is wrong, the citation from which it was extracted provides
important information about the relationship. “This interaction, . . . may reflect the central role of melatonin, i.e. in
synchronising peripheral clock cells that require unique phasing of output signals with the master clock in the brain.”21
Melatonin interacts with CLOCK / CLOCK interacts with Melatonin: “. . . whereas an ‘internal coincidence
model’ best explains the way melatonin affects the phasing of clock gene expression . . . ”22 “In mammals, the noctur-
nal rise in pineal melatonin is regulated by signals from the endogenous clock . . . ”23
Melatonin inhibits Interleukin-1 beta / Melatonin inhibits Interleukin-6 / Melatonin stimulates Interleukin-1
beta / Melatonin stimulates Interleukin-6: “Further melatonin repressed the upregulated levels of expression of
proinflammatory cytokines like, TNF-alpha, IL-1beta and IL-6 in RE.” (in experimental reflux esophagitis)24 “Treat-
ment with melatonin significantly increased the levels of IL- 1beta, IL-6, . . . ” (in collagen-induced arthritis)25
Several predications are about the effect of norepinephrine on either interleukin-1 beta or interleukin-6. We did not
pursue this relationship in this project.
Interleukin-6 stimulates Norepinephrine: For the effect of IL-6 on norepinephrine, all of the predications were
incorrect. Some of them are nonetheless useful in reporting on a reciprocal relationship between IL-6 and nore-
pinephrine, even if a direct interaction is not noted. “In addition, plasma levels of IL-6 and IL-2 were increased in four
stress groups, serum norepinephrine and dopamine were decreased dramatically in stress group and stress low-dose
GTPs modulation group.”26
Interleukin-1 beta inhibits Norepinephrine: “These results suggest that IL-1 beta could decrease NE levels”27
“. . . IL-1beta-induced suppression of the LH surge is most probably mediated through an increase in GABA levels in
the MPA which causes a reduction in NE levels.”28
Interleukin-1 beta stimulates Norepinephrine: “While acute treatment with IL-1beta increased NE concentrations
in both the paraventricular nucleus and the median eminence (ME), chronic treatment increased NE concentrations
only in the ME.”29 “These results indicate that IL-1beta increases NE levels both in the PVN and in the ME and this
could be a possible mechanism by which it stimulates the HPA axis.”30 “We observed that IL-1beta increases the
release of NPY, norepinephrine (NE), and epinephrine (EP) from human chromaffin cells.”31
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Discussion
The methodology presented was illustrated with selected aspects of depressive disorder and focuses on the interaction
of inflammation (particularly the proinflammatory cytokines interleukin-1 beta and interleukin-6), circadian phenom-
ena (clock genes and melatonin), and the neurotransmitter norepinephrine. Below we give an overview of the extent
of current research on these aspects of depression (PubMed queries issued on 03/10/2011) and suggest how our results
may contribute to an understanding of the pathophysiology of this disorder.
There is considerable research investigating circadian phenomena and depression. The PubMed query “(circadian
rhythms[mh] OR clock OR melatonin) AND depression[mh]” returns 331 citations. For example, Kennaway20 reports
on the clock genes and behavioral disorders, including depression. Melatonin figures prominently in this review, but
a mechanism is not proposed. Rosenwasser32 reviews research on the clock genes and psychiatric disorders more
generally, but mechanisms and the connection with inflammation are not highlighted. Our results provide considerable
detail on the mechanisms involved.
Far less research has investigated the interaction of circadian phenomena and inflammation with respect to depression.
The PubMed query “cytokine[mh] AND (circadian rhythms[mh] OR clock OR melatonin) AND depression[mh]” only
returns 18 citations. When limited to reviews, only 8 are retrieved with this query; several are concerned with specific
disorders, such as rheumatologic disorders33 and cancer.34 Only one covers general considerations of the interaction
of circadian phenomena and inflammation.35 Our results suggest details concerning the interaction of melatonin and
the two proinflammatory cytokines interleukin-1 beta and interleukin-6.
The role of inflammation in depression has been extensively studied. The PubMed query “(inflammation OR cy-
tokines) AND depression[mh]” returns 1500 citations (41 reviews). Raison et al.36 and Anisman,37 for example,
provide particularly lucid overviews. Our results are not to be thought of as uncovering the insight that inflammation
is intimately connected with depression (for which there is considerable evidence), but rather they provide additional
information about the interaction of specific cytokines (IL-1 beta and IL-6) and norepinephrine.
Although the noradrenergic system is known to be involved in depression, the mechanistic details are still being in-
vestigated.38 Norepinephrine has not been targeted as intensely as serotonin in therapeutic approaches.39, 40 Only one
norepinephrine reuptake inhibitor (duloxetine) is currently prescribed (in Europe, not in the U.S.).39 Recently, com-
bined serotonin and norepinephrine reuptake inhibitors are being used.41, 42 Although it is known that the cytokines in-
teract with norepinephrine,43 the particular mechanism of IL-1 beta and IL-6 has not been intensively studied (PubMed
query “norepinephrine AND (interleukin-1 beta OR IL-1 beta OR interluekin-6 OR IL-6) AND depression” returns 35
citations). Our results point to considerable evidence of the interaction of IL-6 and IL-1 beta (in particular) in a variety
of contexts beyond cerebral structures, and thus may suggest new avenues for research in explicating the details.
Finally, there is very little research investigating the comprehensive interaction of inflammatory processes, circa-
dian phenomena, and noradrenergic aspects of depression. The specific PubMed query “(interleukin-1 beta OR IL-1
beta OR interluekin-6 OR IL-6) AND melatonin AND norepinephrine AND depression” returns no citations. The
more general “cytokines AND (circadian rhythms[mh] OR clock OR melatonin) AND norepinephrine AND depres-
sion[mh]” returns three citations. One of these39 is a clinically oriented review and does not discuss any of the
mechanisms addressed in this paper. The other two44, 45 cover research more generally, and report substance levels
consistent with our results, but do not suggest mechanisms.
We approached high connectedness by filtering to include only those connections with 10 or more occurrences. One
weakness of this strategy is that it focuses on the more often studied relations at the expense of others. An alternative
approach would be to look at this from the opposite angle, and calculate degree centrality using relations with fewer
occurrences each. This may highlight areas that are highly connected but have not been explored in a coordinated
manner. A second aspect that can be explored is by taking into account the directionality of the relations – incoming
and outgoing relations – and calculating directed paths.
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Conclusion
We introduced a novel LBD methodology incorporating semantic predications and graph analysis that guides re-
searchers through the research literature on a user-specified biomedical phenomenon. A type of “discovery browsing”
exploits graph theoretic paths in order to elucidate poorly understood relationships by providing novel points of view
on some research problem. The user is not required to specify which relationships may serve as a useful guide. A
core aspect of the method is that the user brings to bear domain knowledge as part of the process of navigating in
the selected area of interest. Such “cooperative reciprocity” focuses system output iteratively, thus controlling the
explosion of potential relationships often generated in LBD.
In the method, relationships in MEDLINE citations are represented as a (large) graph of interconnected semantic
predications. The system suggests paths in this graph, which represent interesting chains of relationships. The under-
lying technology depends on semantic predications provided by SemRep, and the graph theoretic constructs degree
centrality and path analysis are particularly exploited.
We illustrated our methodology with depressive disorder, and there are three major components of our results: 1)
inflammation and depression, 2) circadian phenomena and depression, 3) noradrenergic aspects of depression. Varying
amounts of research have been devoted to each of these components, but little (if any) has considered all three together.
Our results do not constitute a discovery in the sense of something previously not noticed by anyone. However,
in several respects they contribute to various aspects of depression that are currently incompletely understood and
have not been extensively studied. Insight into the interrelationships among all these components may materially
contribute to unraveling the underlying pathophysiology of depression, thus underpinning more effective treatment
(and prevention).
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